Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer (Q43910348)

28 November 2017

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer (English)

1 reference

28 November 2017

1 reference

0 references

D Strumberg

1

1 reference

28 November 2017

S Brügge

2

1 reference

28 November 2017

M W Korn

3

1 reference

28 November 2017

S Koeppen

4

1 reference

28 November 2017

J Ranft

5

1 reference

28 November 2017

G Scheiber

6

1 reference

28 November 2017

C Reiners

7

1 reference

28 November 2017

C Möckel

8

1 reference

28 November 2017

S Seeber

9

1 reference

28 November 2017

M E Scheulen

10

1 reference

28 November 2017

1 February 2002

1 reference

28 November 2017

1 reference

28 November 2017

13

1 reference

28 November 2017

229-236

1 reference

28 November 2017

2

1 reference

Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon

28 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Treatment of testicular tumours based on risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Guidelines for the diagnosis and therapy of testicular cancer and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Treatment of disseminated non-seminomatous testicular cancer: the European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

[Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. I. Results of a prospective randomized phase III-study with 71 patients with disseminated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

The symptom check-list, SCL-90-R: its use and characteristics in chronic pain patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

[Otoacoustic emissions (TEOAE and DPOAE) after middle ear operation]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Endocrinological late effects after chemotherapy for testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Long-term sequelae of treatment for testicular germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Peripheral sensory neuropathy and cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Prospective nerve conduction studies in cisplatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Risk factors for ototoxicity due to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Interaction of cisplatin and noise on the peripheral auditory system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Auditory toxicity effects of long-term cis-dichlorodiammineplatinum II therapy in genitourinary cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Long-term effects of chemotherapy in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF058

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDF058

1 reference

28 November 2017

1 reference